Merck & Co., Inc. (BVMF:MRCK34)
Brazil flag Brazil · Delayed Price · Currency is BRL
79.25
+2.76 (3.61%)
Last updated: Feb 27, 2026, 4:34 PM GMT-3

Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of BRL 1.57 trillion. The enterprise value is 1.76 trillion.

Market Cap 1.57T
Enterprise Value 1.76T

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date Feb 3, 2026
Ex-Dividend Date Dec 12, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -1.34%
Shares Change (QoQ) -0.40%
Owned by Insiders (%) 0.05%
Owned by Institutions (%) 80.19%
Float 2.47B

Valuation Ratios

The trailing PE ratio is 15.62 and the forward PE ratio is 24.12.

PE Ratio 15.62
Forward PE 24.12
PS Ratio 4.39
PB Ratio 5.42
P/TBV Ratio 65.62
P/FCF Ratio 23.07
P/OCF Ratio 17.31
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.59, with an EV/FCF ratio of 25.79.

EV / Earnings 17.46
EV / Sales 5.26
EV / EBITDA 11.59
EV / EBIT 13.98
EV / FCF 25.79

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.96.

Current Ratio 1.54
Quick Ratio 0.96
Debt / Equity 0.96
Debt / EBITDA 1.71
Debt / FCF 4.09
Interest Coverage 18.03

Financial Efficiency

Return on equity (ROE) is 36.88% and return on invested capital (ROIC) is 28.30%.

Return on Equity (ROE) 36.88%
Return on Assets (ROA) 12.04%
Return on Invested Capital (ROIC) 28.30%
Return on Capital Employed (ROCE) 22.54%
Weighted Average Cost of Capital (WACC) 5.34%
Revenue Per Employee 4.84M
Profits Per Employee 1.36M
Employee Count 74,000
Asset Turnover 0.51
Inventory Turnover 2.32

Taxes

In the past 12 months, Merck & Co. has paid 15.44 billion in taxes.

Income Tax 15.44B
Effective Tax Rate 13.31%

Stock Price Statistics

The stock price has increased by +19.51% in the last 52 weeks. The beta is 0.30, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y) 0.30
52-Week Price Change +19.51%
50-Day Moving Average 74.02
200-Day Moving Average 61.72
Relative Strength Index (RSI) 55.93
Average Volume (20 Days) 3,644

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 2.12

Income Statement

In the last 12 months, Merck & Co. had revenue of BRL 358.08 billion and earned 100.54 billion in profits. Earnings per share was 40.10.

Revenue 358.08B
Gross Profit 276.48B
Operating Income 134.76B
Pretax Income 116.04B
Net Income 100.54B
EBITDA 160.31B
EBIT 134.76B
Earnings Per Share (EPS) 40.10
Full Income Statement

Balance Sheet

The company has 80.22 billion in cash and 278.34 billion in debt, with a net cash position of -198.12 billion.

Cash & Cash Equivalents 80.22B
Total Debt 278.34B
Net Cash -198.12B
Net Cash Per Share n/a
Equity (Book Value) 290.06B
Book Value Per Share 117.09
Working Capital 83.66B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 90.73 billion and capital expenditures -22.65 billion, giving a free cash flow of 68.08 billion.

Operating Cash Flow 90.73B
Capital Expenditures -22.65B
Free Cash Flow 68.08B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 77.21%, with operating and profit margins of 37.64% and 28.08%.

Gross Margin 77.21%
Operating Margin 37.64%
Pretax Margin 32.41%
Profit Margin 28.08%
EBITDA Margin 44.77%
EBIT Margin 37.64%
FCF Margin 19.01%

Dividends & Yields

This stock pays an annual dividend of 1.53, which amounts to a dividend yield of 1.93%.

Dividend Per Share 1.53
Dividend Yield 1.93%
Dividend Growth (YoY) 5.07%
Years of Dividend Growth 3
Payout Ratio 44.79%
Buyback Yield 1.34%
Shareholder Yield 3.27%
Earnings Yield 6.40%
FCF Yield 4.33%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 29, 2020. It was a forward split with a ratio of 8.

Last Split Date Oct 29, 2020
Split Type Forward
Split Ratio 8

Scores

Merck & Co. has an Altman Z-Score of 3.5 and a Piotroski F-Score of 5.

Altman Z-Score 3.5
Piotroski F-Score 5